Open AccessCase of endophthalmitis following intravitreal injections of bevacizumab
Author(s) -
Sawada Sawada
Publication year - 2010
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s11379
Subject(s) - endophthalmitis , medicine , bevacizumab , vancomycin , ceftazidime , ophthalmology , visual acuity , levofloxacin , staphylococcus epidermidis , ranibizumab , surgery , staphylococcus aureus , antibiotics , microbiology and biotechnology , chemotherapy , pseudomonas aeruginosa , genetics , biology , bacteria
We report a case of infectious endophthalmitis that developed after the third intravitreal injection of bevacizumab. The endophthalmitis was caused by Staphylococcus epidermidis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom